Bio News
The Ministry of Health and Welfare will provide National Health Insurance coverage for Fintepla oral solution, a treatment for Dravet syndrome. Fintepla oral solution completed insurance listing in 126 days through a pilot program that conducts approval, evaluation, and negotiations concurrently. The Ministry of Health and Welfare will also expand coverage for the diffuse large B-cell lymphoma drug Polivy and the pediatric leukemia treatment Blincyto injection.
BIOBOOK TEAM
biobookmedia@biobook.co.krIonkura Reports 20.8-Month Median Survival in Phase 1 Trial for Metastatic Eye Cancer
Verastem’s VS-7375 Shows Response Rates of Up to 50% in Pancreatic Cancer; Phase 3 Trial to Begin This Year
Pfizer to Co-Develop Sec61 Inhibitors With Enodia in Deal Worth Up to $500 Million
Galderma to Acquire ZO Skin Health for $1.5 Billion, Expanding Dermatology Portfolio
Verdiva halts GLP-1 transition trial, citing ‘market changes’
Stryker to Invest $400 Million in CMR Surgical, Expand Robotic Surgery
